np event 2254995 0E193A 1
Jun 11, 2026
- Jun 10, 2027

What Every Family Medicine Physician Should Know About Hepatic Encephalopathy: Recognition, Differential Diagnosis, Diagnostic Testing, and Appropriate Referral

EARNed Credits

1.0

AMA PRA Category 1 CreditTM

iStock-1439770412

Overview

This CME activity is designed to enhance the family medicine physicians understanding of hepatic encephalopathy, with a focus on recognition, differential diagnosis, diagnostic testing, and timely referral. The expert faculty, Dr. Arun Jesudian, will first review the varied clinical presentations of hepatic encephalopathy to facilitate earlier diagnostic consideration and targeted testing. Following, he will examine the evidence supporting diagnostic strategies, including FIB-4 and noninvasive tests such as transient elastography to assess liver fibrosis. Lastly, Dr. Jesudian will discuss the development of practical evaluation, referral strategies, and specialist relationships that facilitate early initiation of optimal hepatic encephalopathy management of affected patients.

Who Should Attend

Family medicine physicians and other primary care providers, internal medicine physicians, hospitalists, hepatologists, advanced practice providers and other healthcare professionals who contribute to the management of patients with hepatic encephalopathy.

Provided By

Course Faculty

Headshot
Arun B. Jesudian, MD
Professor of Clinical Medicine
Director of Liver Quality
Director of Inpatient Liver Services
Weill Cornell Medicine
Division of Gastroenterology and Hepatology
Center for Liver Disease and Transplantation
New York, NY

Learning Objectives

1

Analyze the varied clinical presentations of HE to facilitate earlier diagnostic consideration and targeted testing.

2

Assess the evidence supporting diagnostic strategies, including FIB-4 and noninvasive tests such as transient elastography to assess liver fibrosis, thereby facilitating evidence-based and more timely diagnosis.

3

Develop practical evaluation and referral strategies and specialist relationships that facilitate early initiation of optimal HE management of affected patients.

Course Agenda

Hepatic Encephalopathy: Varied Presentations and Differential Diagnosis

Evidence-Based Testing Strategies for Diagnostic Evaluation of Suspected HE

Indications for Specialist Referral in the Assessment of Patients with Suspected HE

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.

Faculty Relationship Identified With:
Arun Jesudian, MD Consultant/Advisor: BD; Salix Pharmaceuticals

Speaker's Bureau: Madrigal Pharmaceuticals; Mallinckrodt Pharmaceuticals; Novo Nordisk; Salix Pharmaceuticals

Timothy Hayes, MD, PhD; Kim Cheramie, PhD, MSN, RN, NPDA-BC, Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™

Participants should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been supported by an independent educational grant from Salix Pharmaceuticals.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Salix Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
    2. Complete the Pre-Activity Questions
    3. Read or Review the activity content.
    4. Complete the Post-Activity Test Questions and Evaluation.
    5. Learners who receive a grade of 66% or better on the Post-Activity Test Questions andcomplete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  • CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
  • CME and CNE credit will be issued appropriate certificate of completion.
  • Others may request a “certificate of completion”.
  1. Learners should claim only the credit commensurate with the extent of their participation in the activity.

For all CE inquiries or special needs, please contact admin@academiccme.com.

np event 2254995 0E193A 1
Jun 11, 2026
- Jun 10, 2027

What Every Family Medicine Physician Should Know About Hepatic Encephalopathy: Recognition, Differential Diagnosis, Diagnostic Testing, and Appropriate Referral

Related Webcast Courses

No data was found